$1.51 -0.18 (-10.65%)
11/6/2009 3:59 PM

Labopharm, Inc. (DDSS)

CAPS Rating: 3 out of 5

An international, specialty pharmaceutical company focused on improving existing drugs by incorporating its proprietary, advanced controlled-release technologies.

Current Price $1.51 Mkt Cap $86.07M
Open $1.67 P/E Ratio 0.00
Prev. Close $1.69 Div. (Yield) N/A (N/A)
Daily Range $1.46 - $1.68 Volume 847,864
52-Wk Range $0.32 - $2.95 Avg. Daily Vol. 796,000

DDSS News and Commentary

Related News and Articles

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

75 Outperform
12 Underperform
 

All-Star Members

27 Outperform
5 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top DDSS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

phatinvestor007 (95.90)
Submitted January 03, 2009

With approval of their once daily tramadol in the US, and pending approval of trazadone, this company has moved from being a speculative position to one where a profit becomes realizable in the not so distant future. Time will tell if management can… More

msamet1 (95.37)
Submitted March 30, 2007

Drug delivery and reformulation is a crowded sector and requires branded life cycle extensions for strategies to be profitable

DDSS VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about DDSS.

Recs

0
Member Avatar Defshark82 (65.21) Submitted: 8/14/2009 12:36:14 AM : Outperform Start Price: $2.15 DDSS Score: -40.50

The trazodone debacle has hurt the stock recently. However, I see potential in the sales of tramadol. I think with the FDA's recent statements about vicodin and percoset, that it could mean an increase in tramadol prescriptions. If all gets settled with trazodone and approval is granted, Labopharm would have two approved drugs on the market one dealing with pain and one treating depression. I like the upside.

Recs

0
Member Avatar Brian7992 (< 20) Submitted: 8/11/2009 2:29:09 PM : Outperform Start Price: $1.71 DDSS Score: -19.28

Go Baby Go

Recs

0
Member Avatar trueindian25 (20.00) Submitted: 7/3/2009 2:59:39 AM : Outperform Start Price: $2.46 DDSS Score: -59.77

Upcoming FDA approval... The current expectation will drive in a lot of people by July 18.

If approved, it might go higher... atleast 5$

Leaderboard

Find the members with the highest scoring picks in DDSS.

Score Leader

msamet1

msamet1 (95.37) Score: +53.13

The Score Leader is the member with the highest score across all their picks in DDSS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
msamet1 95.37 3/30/2007 Underperform 3Y $5.72 -73.60% -20.47% +53.13 5 Comments
whitewolfkiba 83.26 4/5/2007 Underperform 5Y $5.74 -73.69% -21.17% +52.52
enddreams1 < 20 2/15/2008 Underperform 3W $2.91 -48.11% -17.02% +31.09 1 Comment
jamison08 < 20 8/5/2009 Underperform 5Y $1.90 -20.51% +7.95% +28.46
Kullamity 97.80 6/4/2007 Underperform 5Y $3.04 -50.33% -26.23% +24.09
JayCee788 77.59 6/20/2007 6/30/2008 Underperform NS $3.00 -49.67% -26.57% +23.09
cslewiscap 65.69 6/12/2007 Underperform 3M $2.87 -47.39% -24.83% +22.56
Rhin0man < 20 2/21/2008 Underperform 5Y $2.40 -37.08% -17.49% +19.59
raynlaw 98.58 6/15/2007 Underperform 5Y $2.74 -44.89% -26.36% +18.53
ScrewPollyanna 70.71 4/14/2008 Underperform 5Y $2.04 -25.98% -16.55% +9.43

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRBCCapMkts 81.74 2/22/2007 Outperform NS $6.18 -75.57% -22.21% -53.36
TrackWedbush < 20 2/14/2007 Outperform NS $6.10 -75.25% -21.81% -53.44

Featured Broker Partners